Clinical Trial Update: Cultured White Cells Plus Interleukin-2 to Treat Advanced Kidney Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial of cultured white cells plus Interleukin-2 for advanced kidney cancer was terminated. The update provides no efficacy results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Cancer

Drugs mentioned

• Cultured white cells
• Interleukin-2 (interleukin-2)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Kidney Neoplasms | Phase 1 | Status: TERMINATED